newsfilter
← Latest News
GlobeNewswire·

Can-Fite: Receives Canadian Patent Allowance for Namodenoson as an Anti-Obesity Therapy

Namodenoson's oral safety profile and metabolic activity, position it as a promising candidate in the rapidly growing obesity treatment market Ramat Gan, Israel, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma